verquvo

Bayer launches vericiguat in India to reduce frequent hospitalisations, risk of death in worsening HF patients, Health News, ET HealthWorld

Mumbai: Bayer announced the launch of vericiguat ,Verquvo), a soluble guanylate cyclase (sGC) stimulator, in India. Vericiguat is indicated, along with guideline-based medical therapy, in…